Ratnakar Securities Pvt. Ltd.

SAMRAT PHARMACHEM LTD.

NSE : NABSE : 530125ISIN CODE : INE103E01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE249.802.4 (+0.97 %)

PREV CLOSE ( ) 247.40

OPEN PRICE ( ) 237.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 544

TODAY'S LOW / HIGH ( )237.00 250.00

52 WK LOW / HIGH ( ) 237449.45

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992

Management Info

Lalit Mehta - Chairman Lalit Mehta - Managing Director

Registered Office

Address Plot No A2 / 3445,G I D C, Phase 4,Opp. P C I,
Ankleshwar,
Gujarat-393002

Phone 07045456789 / 07046456789

Email contact@samratpharmachem.in

Website www.samratpharmachem.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE

NEWS

26Sep Samrat Pharmachem submits board meetin
Samrat Pharmachem has enclosed a copy of notice convening Board Meeting..

18Jul Samrat Pharmachem informs about certif
Samrat Pharmachem has informed that it enclosed the Certificate under Re..

16Jul Samrat Pharmachem informs about change
Samrat Pharmachem has informed that the Board of Directors of the Compan..

03Jun Samrat Pharmachem informs about credit
Samrat Pharmachem has informed that Crisil Limited has upgraded its rati..

04Mar Samrat Pharmachem informs about integr
In compliance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/18..

Financials

in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	-5.88000000000008	71.1200000000001
Gross Profit	-7.49000000000008	98.8600000000001
Operating Profit	-3.16000000000008	112.15
Net Sales	788.7	2858.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 16672.15 (3.84%)	M.Cap ( in Cr)21390.18
Eris Lifesciences (BSE) 1701.55 (10.72%)	M.Cap ( in Cr)23177.99
Innova Captab (BSE) 751.85 (12.58%)	M.Cap ( in Cr)4302.46
Sanofi India (BSE) 4344.20 (1.68%)	M.Cap ( in Cr)10004.96
Alkem Laboratories (BSE) 5664.50 (1.16%)	M.Cap ( in Cr)67727.59

Shareholding Pattern

	PROMOTERS	49.09%
	NON-INSTITUTION	47.67%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

SAMRAT PHARMACHEM LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES